Navigating Through the Uncharted Territory of Multisystem Inflammatory Syndrome in Children (MIS-C): What the Pediatric Clinical Nurse Must Know
Noelia MaGowan, Jennifer Darcy, Alexandra Mosiello, Christina Gomes, and Natassia Miller
The New York City area and adjoining counties were one of the hardest hit areas in the nation with SARS-CoV-2, referred to as COVID-19. In the initial months, the impact seemed to spare those in the pediatric population; however, in March 2020, a new finding presented itself. The Centers for Disease Control and Prevention (CDC) (2020a) issued a health advisory regarding a multisystem inflammatory syndrome in children (MIS-C), formerly pediatric multisystem inflammatory syndrome, and its association with COVID-19. They noted that as of October 15, 2020, 44 states and Washington, DC, reported 1,097 cases and 20 deaths. Most pediatric cases are in children 1 to 14 years of age, and slightly more than half (56%) of reported cases were male. According to the New York State Department of Health (NYS DOH) (2020a), as of October 10, 2020, there have been 266 cases of MIS-C under investigation and two pediatric deaths, thereby making this area an epicenter of MIS-C. This article presents a broad view of the educational needs of the clinical nurse caring for the child with multisystem inflammatory syndrome.